FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves a supplemental application for Aldactone (spironolactone) from Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Hyperaldosteronism
• Hypertension
• Nephrotic Syndrome

Drugs mentioned

• Aldactone (spironolactone)

Snippet

SUPPL AP for ALDACTONE (SPIRONOLACTONE)